Innospec (IOSP) 10-Q 8 Nov 17 2017 Q3 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	9 Months Ended
	Sep. 30, 2017	Oct. 31, 2017
Document And Entity Information [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Sep. 30, 2017
Document Fiscal Year Focus	2,017
Document Fiscal Period Focus	Q3
Trading Symbol	IOSP
Entity Registrant Name	INNOSPEC INC.
Entity Central Index Key	1,054,905
Current Fiscal Year End Date	--12-31
Entity Filer Category	Large Accelerated Filer
Entity Common Stock, Shares Outstanding		24,137,575

Condensed Consolidated Statemen

Condensed Consolidated Statements of Income - USD ($) shares in Thousands, $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
Income Statement [Abstract]
Net sales	$ 332.4	$ 205.5	$ 953	$ 645.6
Cost of goods sold	(233.6)	(126.3)	(658.2)	(404.7)
Gross profit	98.8	79.2	294.8	240.9
Operating expenses:
Selling, general and administrative	(60.7)	(56.1)	(176.9)	(153.1)
Research and development	(7.9)	(6.5)	(23.8)	(19.6)
Adjustment to fair value of contingent consideration	0	2.3	0	6.3
Loss on disposal of subsidiary	0	0	(1)	(1.4)
Foreign exchange loss on liquidation of subsidiary	0	0	(1.8)	0
Total operating expenses	(68.6)	(60.3)	(203.5)	(167.8)
Operating income	30.2	18.9	91.3	73.1
Other net income/(expense)	1.8	(5)	2.9	3.2
Interest expense, net	(2.1)	(0.7)	(6.3)	(2.2)
Income before income taxes	29.9	13.2	87.9	74.1
Income taxes	(6.6)	(1.8)	(21.3)	(14.9)
Net income	$ 23.3	$ 11.4	$ 66.6	$ 59.2
Earnings per share:
Basic	$ 0.97	$ 0.48	$ 2.76	$ 2.47
Diluted	$ 0.95	$ 0.47	$ 2.71	$ 2.42
Weighted average shares outstanding (in thousands):
Basic	24,137	23,977	24,119	23,989
Diluted	24,565	24,476	24,569	24,462

Condensed Consolidated Stateme3

Condensed Consolidated Statements of Comprehensive Income - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
Statement of Comprehensive Income [Abstract]
Net income	$ 23.3	$ 11.4	$ 66.6	$ 59.2
Other comprehensive income:
Changes in cumulative translation adjustment, net of tax of $(0.4) million, $0.1 million, $(1.3) million and $(0.7) million, respectively	18.1	(0.1)	30.7	(0.3)
Changes in unrealized gains on derivative instruments, net of tax of $0.0 million, $0.0 million, $0.0 million and $0.0 million, respectively	0.2	0	0.2	0
Amortization of prior service credit, net of tax of $0.0 million, $0.0 million, $0.1 million and $0.1 million, respectively	(0.2)	(0.2)	(0.6)	(0.7)
Amortization of actuarial net losses, net of tax of $(0.1) million, $(0.1) million, $(0.6) million and $(0.4) million, respectively	1.1	0.5	3.1	1.6
Total other comprehensive income	19.2	0.2	33.4	0.6
Total comprehensive income	$ 42.5	$ 11.6	$ 100	$ 59.8

Condensed Consolidated Stateme4

Condensed Consolidated Statements of Comprehensive Income (Parenthetical) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
Statement of Comprehensive Income [Abstract]
Changes in cumulative translation adjustment, tax	$ (0.4)	$ 0.1	$ (1.3)	$ (0.7)
Changes in unrealized gains on derivative instrument, tax	0	0	0	0
Amortization of prior service credit, tax	0	0	0.1	0.1
Amortization of actuarial net losses, tax	$ (0.1)	$ (0.1)	$ (0.6)	$ (0.4)

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($) $ in Millions	Sep. 30, 2017	Dec. 31, 2016
Current assets:
Cash and cash equivalents	$ 65.5	$ 101.9
Trade and other accounts receivable (less allowances of $4.3 million and $4.7 million respectively)	245.6	154.4
Inventories (less allowances of $9.4 million and $8.6 million respectively):
Finished goods	144.7	118.1
Raw materials	66.8	55.7
Total inventories	211.5	173.8
Prepaid expenses	4.1	6.2
Prepaid income taxes	4	4.8
Other current assets	2	0
Total current assets	532.7	441.1
Property, plant and equipment:
Gross cost	312.9	251.8
Less accumulated depreciation	(123.7)	(94.4)
Net property, plant and equipment	189.2	157.4
Goodwill	346.8	374.8
Other intangible assets	169.6	144.4
Deferred tax assets	16.3	14.9
Pension asset	54.9	48
Other non-current assets	3.1	0.8
Total assets	1,312.6	1,181.4
Current liabilities:
Accounts payable	115.7	59.6
Accrued liabilities	94	94.3
Current portion of long-term debt	10.3	10.3
Current portion of finance leases	2.6	1.6
Current portion of plant closure provisions	5.9	6.7
Current portion of accrued income taxes	8.2	9.4
Current portion of acquisition-related contingent consideration	1.1	1.1
Current portion of deferred income	0.1	0.1
Total current liabilities	237.9	183.1
Long-term debt, net of current portion	219	258.5
Finance leases, net of current portion	3.2	2.9
Plant closure provisions, net of current portion	36.8	32.8
Unrecognized tax benefits, net of current portion	1.8	2.3
Deferred tax liabilities	48.6	32.3
Pension liabilities	16.5	14.2
Deferred income, net of current portion	0.5	0.5
Other non-current liabilities	0.4	1
Total liabilities	564.7	527.6
Equity:
Common stock, $0.01 par value, authorized 40,000,000 shares, issued 29,554,500 shares	0.3	0.3
Additional paid-in capital	317.9	315.1
Treasury stock (5,416,924 and 5,483,341 shares at cost, respectively)	(97.1)	(97.5)
Retained earnings	619.2	561.8
Accumulated other comprehensive loss	(92.8)	(126.2)
Total Innospec stockholders' equity	747.5	653.5
Non-controlling interest	0.4	0.3
Total equity	747.9	653.8
Total liabilities and equity	$ 1,312.6	$ 1,181.4

Condensed Consolidated Balance6

Condensed Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Millions	Sep. 30, 2017	Dec. 31, 2016
Statement of Financial Position [Abstract]
Allowances for doubtful accounts	$ 4.3	$ 4.7
Inventory allowances	$ 9.4	$ 8.6
Common stock, par value	$ 0.01	$ 0.01
Common stock, shares authorized	40,000,000	40,000,000
Common stock, shares issued	29,554,500	29,554,500
Treasury stock, shares	5,416,924	5,483,341

Condensed Consolidated Stateme7

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Millions		9 Months Ended
		Sep. 30, 2017	Sep. 30, 2016
Cash Flows from Operating Activities
Net income		$ 66.6	$ 59.2
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	[1]	37.2	28.5
Adjustment to fair value of contingent consideration		0	(6.3)
Deferred taxes		3.7	0.5
Loss on disposal of subsidiary		1	1.4
Foreign exchange loss on liquidation of subsidiary		1.8	0
Cash contributions to defined benefit pension plans		(0.8)	(0.8)
Non-cash movements on defined benefit pension plans		(2.7)	(4.7)
Stock option compensation		3.4	2.8
Changes in assets and liabilities, net of effects of acquired and divested companies:
Trade and other accounts receivable		(83)	12.3
Inventories		(31.5)	(1)
Prepaid expenses		2.2	(3)
Accounts payable and accrued liabilities		42.4	(1)
Accrued income taxes		(2.7)	(0.9)
Plant closure provisions		2.9	1.5
Unrecognized tax benefits		(0.5)	(1.6)
Other assets and liabilities		(4.8)	0.1
Net cash provided by operating activities		35.2	87
Cash Flows from Investing Activities
Capital expenditures		(16.4)	(12.2)
Business combinations, net of cash acquired		2.6	1.8
Acquisition of intangible asset		(4.2)	0
Internally developed software		(4.1)	0
Sale of short-term investments		0	4.7
Net cash used in investing activities		(22.1)	(5.7)
Cash Flows from Financing Activities
Proceeds from revolving credit facility		10	28
Repayments of revolving credit facility		(50)	(18)
Repayments of finance leases		(1.7)	(0.8)
Payment for acquisition-related contingent consideration		0	(44)
Dividend paid		(9.2)	(8.1)
Issue of treasury stock		1	0.3
Repurchase of common stock		(1)	(8.2)
Net cash used in financing activities		(50.9)	(50.8)
Effect of foreign currency exchange rate changes on cash		1.4	(0.3)
Net change in cash and cash equivalents		(36.4)	30.2
Cash and cash equivalents at beginning of period		101.9	136.9
Cash and cash equivalents at end of period		$ 65.5	$ 167.1
[1]	Amortization of deferred finance costs of $0.5 million (2016 - $0.2 million) are included in depreciation and amortization in the consolidated statement of cash flow but in interest expense in the consolidated statement of income.

Condensed Consolidated Stateme8

Condensed Consolidated Statements of Cash Flows (Parenthetical) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016
Statement of Cash Flows [Abstract]
Amortization of deferred finance costs	$ 0.5	$ 0.2

Condensed Consolidated Stateme9

Condensed Consolidated Statement of Equity - 9 months ended Sep. 30, 2017 - USD ($) $ in Millions	Total	Common Stock [Member]	Additional Paid-In Capital [Member]	Treasury Stock [Member]	Retained Earnings [Member]	Accumulated Other Comprehensive Loss [Member]	Non-Controlling Interest [Member]
Beginning Balance at Dec. 31, 2016	$ 653.8	$ 0.3	$ 315.1	$ (97.5)	$ 561.8	$ (126.2)	$ 0.3
Net income	66.6				66.6
Dividend paid	(9.2)				(9.2)
Non-controlling interest	0.1						0.1
Changes in cumulative translation adjustment, net of tax	30.7					30.7
Changes in unrealized gains on derivative instruments, net of tax	0.2					0.2
Treasury stock reissued	0.8		(0.6)	1.4
Treasury stock repurchased	(1)			(1)
Stock option compensation	3.4		3.4
Amortization of prior service credit, net of tax	(0.6)					(0.6)
Amortization of actuarial net losses, net of tax	3.1					3.1
Ending Balance at Sep. 30, 2017	$ 747.9	$ 0.3	$ 317.9	$ (97.1)	$ 619.2	$ (92.8)	$ 0.4

Basis of Presentation

Basis of Presentation	9 Months Ended
	Sep. 30, 2017
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Presentation	NOTE 1 – BASIS OF PRESENTATION The accompanying unaudited interim condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X under the Securities Exchange Act of 1934. Accordingly, they do not include all the information and notes necessary for a comprehensive presentation of financial position, results of operations and cash flows. It is our opinion, however, that all adjustments (consisting of normal, recurring adjustments, unless otherwise disclosed) have been made which are necessary for the condensed consolidated financial statements to be fairly stated. These condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2016 filed on February 15, 2017. The results for the interim period covered by this report are not necessarily indicative of the results to be expected for the full year. When we use the terms “Innospec,” “the Corporation,” “the Company,” “Registrant,” “we,” “us” and “our,” we are referring to Innospec Inc. and its consolidated subsidiaries unless otherwise indicated or the context otherwise requires.

Segment Reporting

Segment Reporting	9 Months Ended
	Sep. 30, 2017
Segment Reporting [Abstract]
Segment Reporting	NOTE 2 – SEGMENT REPORTING The Company reports its financial performance based on the four reportable segments Fuel Specialties, Performance Chemicals, Oilfield Services and Octane Additives. The Fuel Specialties, Performance Chemicals and Oilfield Services segments operate in markets where we actively seek growth opportunities although their ultimate customers are different. The Octane Additives segment is expected to decline in the near future as our one remaining refinery customer transitions to unleaded fuel. The Company evaluates the performance of its segments based on operating income. The following tables analyze sales and other financial information by the Company’s reportable segments: Three Months Ended September 30 Nine Months Ended (in millions) 2017 2016 2017 2016 Net Sales: Refinery and Performance $ 97.4 $ 89.8 $ 286.5 $ 281.7 Other 32.7 24.6 91.3 85.4 Fuel Specialties 130.1 114.4 377.8 367.1 Personal Care 52.2 33.7 148.4 97.7 Home Care 32.7 0.5 89.0 1.4 Other 25.4 2.6 72.3 7.7 Performance Chemicals 110.3 36.8 309.7 106.8 Oilfield Services 81.9 49.7 224.5 132.4 Octane Additives 10.1 4.6 41.0 39.3 $ 332.4 $ 205.5 $ 953.0 $ 645.6 Three Months Ended September 30 Nine Months Ended (in millions) 2017 2016 2017 2016 Net sales: Fuel Specialties $ 130.1 $ 114.4 $ 377.8 $ 367.1 Performance Chemicals 110.3 36.8 309.7 106.8 Oilfield Services 81.9 49.7 224.5 132.4 Octane Additives 10.1 4.6 41.0 39.3 $ 332.4 $ 205.5 $ 953.0 $ 645.6 Gross profit: Fuel Specialties $ 44.6 $ 43.8 $ 135.9 $ 129.5 Performance Chemicals 20.7 12.3 54.8 34.4 Oilfield Services 28.5 20.6 82.9 52.1 Octane Additives 5.0 2.5 21.2 24.9 $ 98.8 $ 79.2 $ 294.8 $ 240.9 Operating income: Fuel Specialties $ 24.9 $ 24.1 $ 75.5 $ 72.2 Performance Chemicals 9.7 4.2 22.2 13.3 Oilfield Services 1.8 0.0 8.5 (7.1 ) Octane Additives 4.4 1.9 19.2 22.5 Pension credit 1.1 1.6 3.2 5.1 Corporate costs (11.7 ) (15.2 ) (34.5 ) (37.8 ) Adjustment to fair value of contingent consideration 0.0 2.3 0.0 6.3 Loss on disposal of subsidiary 0.0 0.0 (1.0 ) (1.4 ) Foreign exchange loss on liquidation of subsidiary 0.0 0.0 (1.8 ) 0.0 Total operating income $ 30.2 $ 18.9 $ 91.3 $ 73.1 The pension credit relates to the United Kingdom defined benefit pension plan which is closed to future service accrual. The charges related to our other much smaller pension arrangements in the U.S. and overseas are included in the segment and income statement captions consistent with the related employees’ costs. The following table presents a summary of the depreciation and amortization charges incurred by the Company’s reportable segments: Three Months Ended September 30 Nine Months Ended (in millions) 2017 2016 2017 2016 Depreciation: Fuel Specialties $ 1.0 $ 0.9 $ 3.0 $ 2.8 Performance Chemicals 2.5 0.5 7.0 1.6 Oilfield Services 1.6 1.7 4.8 4.6 Octane Additives 0.2 0.1 0.6 0.4 Corporate 0.3 0.3 0.7 0.7 $ 5.6 $ 3.5 $ 16.1 $ 10.1 Amortization: Fuel Specialties $ 0.2 $ 0.2 $ 0.6 $ 0.7 Performance Chemicals 1.9 1.1 5.6 3.1 Oilfield Services 2.9 2.9 8.9 8.9 Corporate 1.9 1.9 5.5 5.5 $ 6.9 $ 6.1 $ 20.6 $ 18.2

Earnings Per Share

Earnings Per Share	9 Months Ended
	Sep. 30, 2017
Earnings Per Share [Abstract]
Earnings Per Share	NOTE 3 – EARNINGS PER SHARE Basic earnings per share is based on the weighted average number of common shares outstanding during the period. Diluted earnings per share includes the effect of options that are dilutive and outstanding during the period. Per share amounts are computed as follows: Three Months Ended Nine Months Ended 2017 2016 2017 2016 Numerator (in millions): Net income available to common stockholders $ 23.3 $ 11.4 $ 66.6 $ 59.2 Denominator (in thousands): Weighted average common shares outstanding 24,137 23,977 24,119 23,989 Dilutive effect of stock options and awards 428 499 450 473 Denominator for diluted earnings per share 24,565 24,476 24,569 24,462 Net income per share, basic: $ 0.97 $ 0.48 $ 2.76 $ 2.47 Net income per share, diluted: $ 0.95 $ 0.47 $ 2.71 $ 2.42 In the three and nine months ended September 30, 2017, the average number of anti-dilutive options excluded from the calculation of diluted earnings per share were 18,843 and 18,843, respectively (three and nine months ended September 30, 2016 – 0 and 0, respectively).

Goodwill

Goodwill	9 Months Ended
	Sep. 30, 2017
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill	NOTE 4 – GOODWILL The following table summarizes goodwill at the balance sheet dates: (in millions) Total At December 31, 2016 Gross cost (1) $ 611.3 Accumulated impairment losses (236.5 ) Net book amount $ 374.8 Acquisition adjustment (36.7 ) Exchange effect 8.7 At September 30, 2017 Gross cost (1) $ 583.3 Accumulated impairment losses (236.5 ) Net book amount $ 346.8 ( 1 ) Gross cost for 2017 and 2016 is net of $298.5 million of historical accumulated amortization. Acquisition of Huntsman European Differentiated Surfactants Business On December 30, 2016 the Company acquired the European Differentiated Surfactants business (“Huntsman”) from Huntsman Investments (Netherlands) B.V. for a total consideration of $200.2 million. During the year we have reviewed the fair values of assets acquired and liabilities assumed resulting in a $36.7 million increase in assets acquired and a corresponding decrease in goodwill. The final working capital adjustments of $2.6 million were agreed in the third quarter of 2017. The measurement period for the valuation of assets acquired and liabilities assumed ends as soon as information on the facts and circumstances that existed as of the acquisition dates become available but does not exceed twelve months. The final fair value of assets and liabilities has not been determined as at September 30, 2017. Huntsman, and the associated goodwill and other intangible assets, are included within our Performance Chemicals segment for management and reporting purposes. There is currently no goodwill amortizable for tax purposes.

Other Intangible Assets

Other Intangible Assets	9 Months Ended
	Sep. 30, 2017
Goodwill and Intangible Assets Disclosure [Abstract]
Other Intangible Assets	NOTE 5 – OTHER INTANGIBLE ASSETS The following table summarizes the other intangible assets movement year on year: Nine Months Ended September 30 (in millions) 2017 2016 Gross cost at January 1 $ 248.6 $ 248.6 Acquisitions 37.7 0.0 Internally developed software 4.1 0.0 Exchange effect 4.1 0.0 Gross cost at September 30 294.5 248.6 Accumulated amortization at January 1 (104.2 ) (79.9 ) Amortization expense (20.6 ) (18.2 ) Exchange effect (0.1 ) 0.0 Accumulated amortization at September 30 (124.9 ) (98.1 ) Net book amount at September 30 $ 169.6 $ 150.5 Acquisitions in the year are related to the Huntsman acquisition based on our provisional assessment of the fair value of the other intangible assets acquired. In the first quarter of 2017 we allocated $33.5 million of goodwill to intangibles relating to the acquisition completed on December 30, 2016. The intangible assets relate to customer relationships. In addition, the Company completed the acquisition of customer and distributor lists in the Americas and Asia Pacific from Huntsman Holland B.V. for $4.2 million in cash on August 9, 2017. Internally developed software has been capitalized in relation to a new information system platform for the acquired Huntsman business. Amortization expense Nine Months Ended September 30 (in millions) 2017 2016 Product rights $ (2.8 ) $ (2.8 ) Brand names (0.9 ) (0.9 ) Technology (2.5 ) (2.5 ) Customer relationships (7.6 ) (5.1 ) Non-compete agreements (0.6 ) (0.7 ) Marketing related (0.7 ) (0.7 ) Internally developed software (5.5 ) (5.5 ) Total $ (20.6 ) $ (18.2 )

Pension Plans

Pension Plans	9 Months Ended
	Sep. 30, 2017
Retirement Benefits [Abstract]
Pension Plans	NOTE 6 – PENSION PLANS The Company maintains a defined benefit pension plan (the “Plan”) covering a number of its current and former employees in the United Kingdom, although it does also have other much smaller pension arrangements in the U.S. and overseas. The Plan is closed to future service accrual but has a large number of deferred and current pensioners. Three Months Ended September 30 Nine Months Ended (in millions) 2017 2016 2017 2016 Plan net pension credit/(charge): Service cost $ (0.2 ) $ (0.2 ) $ (0.7 ) $ (0.7 ) Interest cost on projected benefit obligation (3.9 ) (5.0 ) (11.3 ) (16.0 ) Expected return on plan assets 6.2 7.2 18.2 23.0 Amortization of prior service credit 0.2 0.2 0.7 0.8 Amortization of actuarial net losses (1.2 ) (0.6 ) (3.7 ) (2.0 ) $ 1.1 $ 1.6 $ 3.2 $ 5.1 The amortization of prior service credit and actuarial net losses is a reclassification out of accumulated other comprehensive loss into selling, general and administrative expenses. The Company also maintains an unfunded defined benefit pension plan covering a number of its current and former employees in Germany (the “German plan”). The German plan is closed to new entrants and has no assets. The net pension charge for the German plan for the three and nine months ended September 30, 2017 was $0.1 million and $0.5 million, respectively (three and nine months ended September 30, 2016 - $0.2 million and $0.6 million, respectively). As at September 30, 2017, our Performance Chemicals segment has pension obligations in its European businesses with a liability of $4.7 million (December 31, 2016 - $4.1 million).

Income Taxes

Income Taxes	9 Months Ended
	Sep. 30, 2017
Income Tax Disclosure [Abstract]
Income Taxes	NOTE 7 – INCOME TAXES A roll-forward of unrecognized tax benefits and associated accrued interest and penalties is as follows: (in millions) Unrecognized Interest and Total Opening balance at January 1, 2017 $ 2.2 $ 0.1 $ 2.3 Reductions due to lapsed statute of limitations (0.5 ) 0.0 (0.5 ) Closing balance at September 30, 2017 1.7 0.1 1.8 Current 0.0 0.0 0.0 Non-current $ 1.7 $ 0.1 $ 1.8 All of the unrecognized tax benefits, interest and penalties would impact our effective tax rate if recognized. We recognize accrued interest and penalties associated with uncertain tax positions as part of income taxes in our condensed consolidated statements of income. The Company or one of its subsidiaries files income tax returns with the U.S. federal government, and various state and foreign jurisdictions. As previously disclosed, one of the Company’s U.S. subsidiaries is currently subject to a state tax examination in respect of 2012 through to 2014 inclusive, and the Company and its U.S. subsidiaries are currently subject to a federal income tax examination in respect of 2015. The Company currently anticipates that adjustments, if any, arising out of these tax audits would not result in a material change to the Company’s financial position as at September 30, 2017. The Company and its U.S. subsidiaries remain open to examination by the IRS for years 2014 onwards. The Company’s subsidiaries in foreign tax jurisdictions are open to examination including France (2014 onwards), Germany (2015 onwards), Switzerland (2015 onwards) and the United Kingdom (2015 onwards). Tax audits have been opened by the Italian tax authorities in respect of Innospec Performance Chemicals Italia Srl, acquired as part of the Huntsman business in respect of the period 2011 to 2013 inclusive. Any additional tax arising as a consequence of the tax audit would be a liability of the previous owner under the terms of the sales and purchase agreement. The Company is in a position to control whether or not to repatriate foreign earnings and we currently do not expect to make a repatriation in the foreseeable future. No taxes have been provided for on the unremitted earnings of our overseas subsidiaries as any tax basis differences relating to investments in these overseas subsidiaries are considered to be indefinite in duration. The amount of unremitted earnings at December 31, 2016 was approximately $788 million. If these earnings are remitted, additional taxes could result after offsetting foreign income taxes paid although the calculation of the additional taxes is not practicable to compute at this time.

Long-Term Debt

Long-Term Debt	9 Months Ended
	Sep. 30, 2017
Debt Disclosure [Abstract]
Long-Term Debt	NOTE 8 – LONG-TERM DEBT Long-term debt consists of the following: (in millions) September 30, 2017 December 31, 2016 Revolving credit facility $ 121.0 $ 161.0 Term loan 110.0 110.0 Deferred finance costs (1.7 ) (2.2 ) $ 229.3 $ 268.8 Due within one year (10.3 ) (10.3 ) Due after one year $ 219.0 $ 258.5

Plant Closure Provisions

Plant Closure Provisions	9 Months Ended
	Sep. 30, 2017
Restructuring and Related Activities [Abstract]
Plant Closure Provisions	NOTE 9 – PLANT CLOSURE PROVISIONS The liability for estimated closure costs of Innospec’s manufacturing facilities includes costs for decontamination and environmental remediation activities (“remediation”). The principal site giving rise to remediation liabilities is the manufacturing site at Ellesmere Port in the United Kingdom. There are also remediation liabilities on a much smaller scale in respect of our other manufacturing sites in the U.S. and Europe. Movements in the provisions are summarized as follows: Nine Months Ended (in millions) 2017 2016 Total at January 1 $ 39.5 $ 37.7 Charge for the period 4.4 3.5 Utilized in the period (1.7 ) (2.1 ) Exchange effect 0.5 0.1 Total at September 30 42.7 39.2 Due within one year (5.9 ) (5.0 ) Due after one year $ 36.8 $ 34.2 Amounts due within one year refer to provisions where expenditure is expected to arise within one year of the balance sheet date.

Fair Value Measurements

Fair Value Measurements	9 Months Ended
	Sep. 30, 2017
Fair Value Disclosures [Abstract]
Fair Value Measurements	NOTE 10 – FAIR VALUE MEASUREMENTS The following table presents the carrying amount and fair values of the Company’s assets and liabilities measured on a recurring basis: September 30, 2017 December 31, 2016 (in millions) Carrying Amount Fair Value Carrying Amount Fair Value Assets Non-derivatives: Cash and cash equivalents $ 65.5 $ 65.5 $ 101.9 $ 101.9 Derivatives (Level 1 measurement): Other current and non-current assets: Foreign currency forward exchange contracts 2.0 2.0 0.0 0.0 Interest rate swaps 0.6 0.6 0.4 0.4 Liabilities Non-derivatives: Long-term debt (including current portion) $ 229.3 $ 229.3 $ 268.8 $ 268.8 Finance leases (including current portion) 5.8 5.8 4.5 4.5 Derivatives (Level 1 measurement): Other non-current liabilities: Foreign currency forward exchange contracts 0.0 0.0 0.6 0.6 Non-financial liabilities (Level 3 measurement): Stock equivalent units 11.4 11.4 9.8 9.8 The following methods and assumptions were used to estimate the fair values of financial instruments: Cash and cash equivalents: Long-term debt and finance leases: Derivatives: Stock equivalent units:

Derivative Instruments and Risk

Derivative Instruments and Risk Management	9 Months Ended
	Sep. 30, 2017
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Instruments and Risk Management	NOTE 11 – DERIVATIVE INSTRUMENTS AND RISK MANAGEMENT The Company enters into various foreign currency forward exchange contracts to minimize currency exchange rate exposure from expected future cash flows. As at September 30, 2017 the contracts have maturity dates of up to twelve months at the date of inception. These foreign currency forward exchange contracts have not been designated as hedging instruments, and their impact on the income statement for the first nine months of 2017 was a loss of $0.6 million (first nine months of 2016: gain of $3.2 million). The Company enters into interest rate swaps to minimize interest rate exposure related to a part of our borrowing requirements. These interest rate swaps have been designated as hedging instruments, and their impact on accumulated other comprehensive loss for the first nine months of 2017 was a gain of $0.2 million (first nine months of 2016: $0.0 million).

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
	Sep. 30, 2017
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	NOTE 12 – COMMITMENTS AND CONTINGENCIES Legal matters While we are involved from time to time in claims and legal proceedings that result from, and are incidental to, the conduct of our business including business and commercial litigation, employee and product liability claims, there are no material pending legal proceedings to which the Company or any of its subsidiaries is a party, or of which any of their property is subject. It is possible, however, that an adverse resolution of an unexpectedly large number of such individual claims or proceedings could in the aggregate have a material adverse effect on the results of operations for a particular year or quarter. Guarantees The Company and certain of the Company’s consolidated subsidiaries are contingently liable for certain obligations of affiliated companies primarily in the form of guarantees of debt and performance under contracts entered into as a normal business practice. This includes guarantees of non-U.S. excise taxes and customs duties. As at September 30, 2017, such guarantees which are not recognized as liabilities in the condensed consolidated financial statements amounted to $3.3 million. Under the terms of the guarantee arrangements, generally the Company would be required to perform should the affiliated company fail to fulfil its obligations under the arrangements. In some cases, the guarantee arrangements have recourse provisions that would enable the Company to recover any payments made under the terms of the guarantees from securities held of the guaranteed parties’ assets. The Company and its affiliates have numerous long-term sales and purchase commitments in their various business activities, which are expected to be fulfilled with no adverse consequences material to the Company.

Stock-Based Compensation Plans

Stock-Based Compensation Plans	9 Months Ended
	Sep. 30, 2017
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Stock-Based Compensation Plans	NOTE 13 – STOCK-BASED COMPENSATION PLANS The Company grants stock options and stock equivalent units (“SEUs”) from time to time as a long-term performance incentive. In certain cases the grants are subject to performance conditions such as the Company’s stock price. Where performance conditions apply the Monte Carlo simulation model is used to determine the fair values. Otherwise the Black-Scholes model is used to determine the fair values. Stock option plans The following table summarizes the transactions of the Company’s stock option plans for the nine months ended September 30, 2017: Number of Weighted Weighted Grant-Date Fair Value Outstanding at December 31, 2016 570,994 $ 20.38 $ 21.68 Granted - at discount 79,664 $ 0.00 $ 61.39 - at market value 18,843 $ 70.60 $ 16.84 Exercised (83,255 ) $ 12.56 $ 23.86 Forfeited (3,805 ) $ 15.91 $ 22.47 Outstanding at September 30, 2017 582,441 $ 20.64 $ 26.68 At September 30, 2017, there were 44,443 stock options that were exercisable, of which 9,421 had performance conditions attached. The stock option compensation cost for the first nine months of 2017 was $3.4 million (first nine months of 2016 – $2.8 million). The total intrinsic value of options exercised in the first nine months of 2017 was $2.0 million (first nine months of 2016 – $1.8 million). The total compensation cost related to non-vested stock options not yet recognized at September 30, 2017 was $6.7 million and this cost is expected to be recognized over the weighted-average period of 2.05 years. Stock equivalent units The following table summarizes the transactions of the Company’s SEUs for the nine months ended September 30, 2017: Number Weighted Weighted Grant-Date Outstanding at December 31, 2016 279,815 $ 3.77 $ 33.40 Granted - at discount 180,249 $ 0.00 $ 62.76 - at market value 5,530 $ 70.60 $ 16.84 Exercised (34,054 ) $ 5.47 $ 27.09 Forfeited (16,075 ) $ 0.00 $ 33.77 Outstanding at September 30, 2017 415,465 $ 3.03 $ 46.41 At September 30, 2017 there were 54,759 SEUs that are exercisable, of which 49,391 had performance conditions attached. The charges for SEUs are spread over the life of the award subject to a revaluation to fair value each quarter. The revaluation may result in a charge or a credit to the income statement in the quarter dependent upon our share price and other performance criteria. The SEU compensation cost for the first nine months of 2017 was $3.6 million (first nine months of 2016 – $3.7 million). The total intrinsic value of SEUs exercised in the first nine months of 2017 was $1.1 million (first nine months of 2016 – $1.5 million). The weighted-average remaining vesting period of non-vested SEUs is 1.93 years.

Reclassifications out of Accumu

Reclassifications out of Accumulated Other Comprehensive Loss	9 Months Ended
	Sep. 30, 2017
Equity [Abstract]
Reclassifications out of Accumulated Other Comprehensive Loss	NOTE 14 – RECLASSIFICATIONS OUT OF ACCUMULATED OTHER COMPREHENSIVE LOSS Reclassifications out of accumulated other comprehensive loss for the first nine months of 2017 were: (in millions) Details about AOCL Components Amount Affected Line Item in the Statement where Net Income is Presented Foreign currency translation items: Liquidation of subsidiary $ 1.8 Loss on liquidation of subsidiary Defined benefit pension plan items: Amortization of prior service credit $ (0.7 ) See ( ) Amortization of actuarial net losses 3.7 See ( ) 4.8 Total before tax (0.5 ) Income tax expense Total reclassifications $ 4.3 Net of tax (1) These items are included in the computation of net periodic pension cost. See Note 6 of the Notes to the Condensed Consolidated Financial Statements for additional information. Changes in accumulated other comprehensive loss for the first nine months of 2017, net of tax, were: (in millions) Derivative Defined Cumulative Total Balance at December 31, 2016 $ 0.3 $ (46.0 ) $ (80.5 ) $ (126.2 ) Other comprehensive income before reclassifications 0.2 0.0 30.7 30.9 Amounts reclassified from AOCL 0.0 2.5 0.0 2.5 Total other comprehensive income 0.2 2.5 30.7 33.4 Balance at September 30, 2017 $ 0.5 $ (43.5 ) $ (49.8 ) $ (92.8 )

Recently Issued Accounting Pron

Recently Issued Accounting Pronouncements	9 Months Ended
	Sep. 30, 2017
Accounting Changes and Error Corrections [Abstract]
Recently Issued Accounting Pronouncements	NOTE 15 – RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTS In March 2017, the FASB issued ASU 2017-07, Compensation—Retirement Benefits (Topic 715): Improving the Presentation of Net Periodic Pension Cost and Net Periodic Postretirement Benefit Cost. ASU 2017-07 requires companies to present the service cost component of net benefit cost in the same line items in which they report compensation cost. Companies will present all other components of net benefit cost outside operating income, if this subtotal is presented. The new standard is effective for annual periods beginning after December 15, 2017, including interim periods within those fiscal years. The Company has not yet determined the effect of the standard on its ongoing financial reporting. In February 2016, the FASB issued Accounting Standards Update (ASU) 2016-02, Revision to Lease Accounting, which amends ASC Topic 842, Leases. The ASU requires lessees to recognize a right-of-use asset and a lease liability for virtually all of their leases (other than leases that meet the definition of a short-term lease). The new standard is effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. Early adoption is permitted. The new standard must be adopted using a modified retrospective transition, and provides for certain practical expedients. Transition will require application of the new guidance at the beginning of the earliest comparative period presented. The Company has not yet determined the effect of the standard on its ongoing financial reporting. In May 2014, the FASB issued Accounting Standards Update (ASU) 2014-09, Revenue from Contracts with Customers (Topic 606) We are spending significant time and efforts evaluating, analyzing and documenting the expected impact of ASU 2014-09 on our financial statements. Our approach includes performing a detailed review of key contracts representative of our different businesses and product lines, reviewing various industry publications, and comparing our current accounting policies to the principles and requirements outlined in the new standard. Our assessment at this stage is that we do not expect the new revenue recognition standard will have a material impact on our financial statements upon adoption.

Related Party Transactions

Related Party Transactions	9 Months Ended
	Sep. 30, 2017
Related Party Transactions [Abstract]
Related Party Transactions	NOTE 16 – RELATED PARTY TRANSACTIONS Mr. Robert I. Paller has been a non-executive director of the Company since November 1, 2009. The Company has retained and continues to retain Smith, Gambrell & Russell, LLP (“SGR”), a law firm with which Mr. Paller holds a position. In the first nine months of 2017 the Company incurred fees from SGR of $0.3 million (first nine months of 2016 – $0.4 million). As at September 30, 2017, the amount due to SGR from the Company was $0.0 million (December 31, 2016 - $0.0 million).

Segment Reporting (Tables)

Segment Reporting (Tables)	9 Months Ended
	Sep. 30, 2017
Segment Reporting [Abstract]
Segment Reporting	The following tables analyze sales and other financial information by the Company’s reportable segments: Three Months Ended September 30 Nine Months Ended (in millions) 2017 2016 2017 2016 Net Sales: Refinery and Performance $ 97.4 $ 89.8 $ 286.5 $ 281.7 Other 32.7 24.6 91.3 85.4 Fuel Specialties 130.1 114.4 377.8 367.1 Personal Care 52.2 33.7 148.4 97.7 Home Care 32.7 0.5 89.0 1.4 Other 25.4 2.6 72.3 7.7 Performance Chemicals 110.3 36.8 309.7 106.8 Oilfield Services 81.9 49.7 224.5 132.4 Octane Additives 10.1 4.6 41.0 39.3 $ 332.4 $ 205.5 $ 953.0 $ 645.6 Three Months Ended September 30 Nine Months Ended (in millions) 2017 2016 2017 2016 Net sales: Fuel Specialties $ 130.1 $ 114.4 $ 377.8 $ 367.1 Performance Chemicals 110.3 36.8 309.7 106.8 Oilfield Services 81.9 49.7 224.5 132.4 Octane Additives 10.1 4.6 41.0 39.3 $ 332.4 $ 205.5 $ 953.0 $ 645.6 Gross profit: Fuel Specialties $ 44.6 $ 43.8 $ 135.9 $ 129.5 Performance Chemicals 20.7 12.3 54.8 34.4 Oilfield Services 28.5 20.6 82.9 52.1 Octane Additives 5.0 2.5 21.2 24.9 $ 98.8 $ 79.2 $ 294.8 $ 240.9 Operating income: Fuel Specialties $ 24.9 $ 24.1 $ 75.5 $ 72.2 Performance Chemicals 9.7 4.2 22.2 13.3 Oilfield Services 1.8 0.0 8.5 (7.1 ) Octane Additives 4.4 1.9 19.2 22.5 Pension credit 1.1 1.6 3.2 5.1 Corporate costs (11.7 ) (15.2 ) (34.5 ) (37.8 ) Adjustment to fair value of contingent consideration 0.0 2.3 0.0 6.3 Loss on disposal of subsidiary 0.0 0.0 (1.0 ) (1.4 ) Foreign exchange loss on liquidation of subsidiary 0.0 0.0 (1.8 ) 0.0 Total operating income $ 30.2 $ 18.9 $ 91.3 $ 73.1
Summary of Segment Depreciation and Amortization	The following table presents a summary of the depreciation and amortization charges incurred by the Company’s reportable segments: Three Months Ended September 30 Nine Months Ended (in millions) 2017 2016 2017 2016 Depreciation: Fuel Specialties $ 1.0 $ 0.9 $ 3.0 $ 2.8 Performance Chemicals 2.5 0.5 7.0 1.6 Oilfield Services 1.6 1.7 4.8 4.6 Octane Additives 0.2 0.1 0.6 0.4 Corporate 0.3 0.3 0.7 0.7 $ 5.6 $ 3.5 $ 16.1 $ 10.1 Amortization: Fuel Specialties $ 0.2 $ 0.2 $ 0.6 $ 0.7 Performance Chemicals 1.9 1.1 5.6 3.1 Oilfield Services 2.9 2.9 8.9 8.9 Corporate 1.9 1.9 5.5 5.5 $ 6.9 $ 6.1 $ 20.6 $ 18.2

Earnings Per Share (Tables)

Earnings Per Share (Tables)	9 Months Ended
	Sep. 30, 2017
Earnings Per Share [Abstract]
Summary of Earnings Per Share	Per share amounts are computed as follows: Three Months Ended Nine Months Ended 2017 2016 2017 2016 Numerator (in millions): Net income available to common stockholders $ 23.3 $ 11.4 $ 66.6 $ 59.2 Denominator (in thousands): Weighted average common shares outstanding 24,137 23,977 24,119 23,989 Dilutive effect of stock options and awards 428 499 450 473 Denominator for diluted earnings per share 24,565 24,476 24,569 24,462 Net income per share, basic: $ 0.97 $ 0.48 $ 2.76 $ 2.47 Net income per share, diluted: $ 0.95 $ 0.47 $ 2.71 $ 2.42

Goodwill (Tables)

Goodwill (Tables)	9 Months Ended
	Sep. 30, 2017
Goodwill and Intangible Assets Disclosure [Abstract]
Summary of Goodwill	The following table summarizes goodwill at the balance sheet dates: (in millions) Total At December 31, 2016 Gross cost (1) $ 611.3 Accumulated impairment losses (236.5 ) Net book amount $ 374.8 Acquisition adjustment (36.7 ) Exchange effect 8.7 At September 30, 2017 Gross cost (1) $ 583.3 Accumulated impairment losses (236.5 ) Net book amount $ 346.8 ( 1 ) Gross cost for 2017 and 2016 is net of $298.5 million of historical accumulated amortization.

Other Intangible Assets (Tables

Other Intangible Assets (Tables)	9 Months Ended
	Sep. 30, 2017
Goodwill and Intangible Assets Disclosure [Abstract]
Summary of Other Intangible Assets	The following table summarizes the other intangible assets movement year on year: Nine Months Ended September 30 (in millions) 2017 2016 Gross cost at January 1 $ 248.6 $ 248.6 Acquisitions 37.7 0.0 Internally developed software 4.1 0.0 Exchange effect 4.1 0.0 Gross cost at September 30 294.5 248.6 Accumulated amortization at January 1 (104.2 ) (79.9 ) Amortization expense (20.6 ) (18.2 ) Exchange effect (0.1 ) 0.0 Accumulated amortization at September 30 (124.9 ) (98.1 ) Net book amount at September 30 $ 169.6 $ 150.5
Schedule of Amortization Expense	Amortization expense Nine Months Ended September 30 (in millions) 2017 2016 Product rights $ (2.8 ) $ (2.8 ) Brand names (0.9 ) (0.9 ) Technology (2.5 ) (2.5 ) Customer relationships (7.6 ) (5.1 ) Non-compete agreements (0.6 ) (0.7 ) Marketing related (0.7 ) (0.7 ) Internally developed software (5.5 ) (5.5 ) Total $ (20.6 ) $ (18.2 )

Pension Plans (Tables)

Pension Plans (Tables)	9 Months Ended
	Sep. 30, 2017
Retirement Benefits [Abstract]
Defined Benefit Pension Plan	Three Months Ended September 30 Nine Months Ended (in millions) 2017 2016 2017 2016 Plan net pension credit/(charge): Service cost $ (0.2 ) $ (0.2 ) $ (0.7 ) $ (0.7 ) Interest cost on projected benefit obligation (3.9 ) (5.0 ) (11.3 ) (16.0 ) Expected return on plan assets 6.2 7.2 18.2 23.0 Amortization of prior service credit 0.2 0.2 0.7 0.8 Amortization of actuarial net losses (1.2 ) (0.6 ) (3.7 ) (2.0 ) $ 1.1 $ 1.6 $ 3.2 $ 5.1

Income Taxes (Tables)

Income Taxes (Tables)	9 Months Ended
	Sep. 30, 2017
Income Tax Disclosure [Abstract]
Roll-Forward of Unrecognized Tax Benefits and Associated Accrued Interest and Penalties	A roll-forward of unrecognized tax benefits and associated accrued interest and penalties is as follows: (in millions) Unrecognized Interest and Total Opening balance at January 1, 2017 $ 2.2 $ 0.1 $ 2.3 Reductions due to lapsed statute of limitations (0.5 ) 0.0 (0.5 ) Closing balance at September 30, 2017 1.7 0.1 1.8 Current 0.0 0.0 0.0 Non-current $ 1.7 $ 0.1 $ 1.8

Long-Term Debt (Tables)

Long-Term Debt (Tables)	9 Months Ended
	Sep. 30, 2017
Debt Disclosure [Abstract]
Schedule of Long-Term Debt	Long-term debt consists of the following: (in millions) September 30, 2017 December 31, 2016 Revolving credit facility $ 121.0 $ 161.0 Term loan 110.0 110.0 Deferred finance costs (1.7 ) (2.2 ) $ 229.3 $ 268.8 Due within one year (10.3 ) (10.3 ) Due after one year $ 219.0 $ 258.5

Plant Closure Provisions (Table

Plant Closure Provisions (Tables)	9 Months Ended
	Sep. 30, 2017
Restructuring and Related Activities [Abstract]
Movements in Plant Closure and Restructuring Provisions	Movements in the provisions are summarized as follows: Nine Months Ended (in millions) 2017 2016 Total at January 1 $ 39.5 $ 37.7 Charge for the period 4.4 3.5 Utilized in the period (1.7 ) (2.1 ) Exchange effect 0.5 0.1 Total at September 30 42.7 39.2 Due within one year (5.9 ) (5.0 ) Due after one year $ 36.8 $ 34.2

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	9 Months Ended
	Sep. 30, 2017
Fair Value Disclosures [Abstract]
Carrying Amount and Fair Values of the Company's Assets and Liabilities Measured on a Recurring Basis	The following table presents the carrying amount and fair values of the Company’s assets and liabilities measured on a recurring basis: September 30, 2017 December 31, 2016 (in millions) Carrying Amount Fair Value Carrying Amount Fair Value Assets Non-derivatives: Cash and cash equivalents $ 65.5 $ 65.5 $ 101.9 $ 101.9 Derivatives (Level 1 measurement): Other current and non-current Foreign currency forward exchange contracts 2.0 2.0 0.0 0.0 Interest rate swaps 0.6 0.6 0.4 0.4 Liabilities Non-derivatives: Long-term debt (including current portion) $ 229.3 $ 229.3 $ 268.8 $ 268.8 Finance leases (including current portion) 5.8 5.8 4.5 4.5 Derivatives (Level 1 measurement): Other non-current Foreign currency forward exchange contracts 0.0 0.0 0.6 0.6 Non-financial Stock equivalent units 11.4 11.4 9.8 9.8

Stock-Based Compensation Plans

Stock-Based Compensation Plans (Tables)	9 Months Ended
	Sep. 30, 2017
Stock Options Plan [Member]
Summary of Transactions of Company's Stock Option Plans	The following table summarizes the transactions of the Company’s stock option plans for the nine months ended September 30, 2017: Number of Weighted Weighted Grant-Date Fair Value Outstanding at December 31, 2016 570,994 $ 20.38 $ 21.68 Granted - at discount 79,664 $ 0.00 $ 61.39 - at market value 18,843 $ 70.60 $ 16.84 Exercised (83,255 ) $ 12.56 $ 23.86 Forfeited (3,805 ) $ 15.91 $ 22.47 Outstanding at September 30, 2017 582,441 $ 20.64 $ 26.68
Stock Equivalent Units [Member]
Summarizes Transactions of SEUs	The following table summarizes the transactions of the Company’s SEUs for the nine months ended September 30, 2017: Number Weighted Weighted Grant-Date Outstanding at December 31, 2016 279,815 $ 3.77 $ 33.40 Granted - at discount 180,249 $ 0.00 $ 62.76 - at market value 5,530 $ 70.60 $ 16.84 Exercised (34,054 ) $ 5.47 $ 27.09 Forfeited (16,075 ) $ 0.00 $ 33.77 Outstanding at September 30, 2017 415,465 $ 3.03 $ 46.41

Reclassifications out of Accu36

Reclassifications out of Accumulated Other Comprehensive Loss (Tables)	9 Months Ended
	Sep. 30, 2017
Equity [Abstract]
Summary of Reclassifications Out of Accumulated Other Comprehensive Loss	Reclassifications out of accumulated other comprehensive loss for the first nine months of 2017 were: (in millions) Details about AOCL Components Amount Affected Line Item in the Statement where Net Income is Presented Foreign currency translation items: Liquidation of subsidiary $ 1.8 Loss on liquidation of subsidiary Defined benefit pension plan items: Amortization of prior service credit $ (0.7 ) See ( ) Amortization of actuarial net losses 3.7 See ( ) 4.8 Total before tax (0.5 ) Income tax expense Total reclassifications $ 4.3 Net of tax (1) These items are included in the computation of net periodic pension cost. See Note 6 of the Notes to the Condensed Consolidated Financial Statements for additional information.
Changes in Accumulated Other Comprehensive Loss	Changes in accumulated other comprehensive loss for the first nine months of 2017, net of tax, were: (in millions) Derivative Defined Cumulative Total Balance at December 31, 2016 $ 0.3 $ (46.0 ) $ (80.5 ) $ (126.2 ) Other comprehensive income before reclassifications 0.2 0.0 30.7 30.9 Amounts reclassified from AOCL 0.0 2.5 0.0 2.5 Total other comprehensive income 0.2 2.5 30.7 33.4 Balance at September 30, 2017 $ 0.5 $ (43.5 ) $ (49.8 ) $ (92.8 )

Segment Reporting - Additional

Segment Reporting - Additional Information (Detail)	9 Months Ended
	Sep. 30, 2017Segment
Segment Reporting [Abstract]
Number of reportable segments	4

Segment Reporting - Segment Rep

Segment Reporting - Segment Reporting (Detail) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
Segment Reporting Information [Line Items]
Net sales	$ 332.4	$ 205.5	$ 953	$ 645.6
Gross profit	98.8	79.2	294.8	240.9
Adjustment to fair value of contingent consideration	0	2.3	0	6.3
Loss on disposal of subsidiary	0	0	(1)	(1.4)
Foreign exchange loss on liquidation of subsidiary	0	0	(1.8)	0
Operating income	30.2	18.9	91.3	73.1
Operating Segments [Member] | Fuel Specialties [Member]
Segment Reporting Information [Line Items]
Net sales	130.1	114.4	377.8	367.1
Gross profit	44.6	43.8	135.9	129.5
Operating income	24.9	24.1	75.5	72.2
Operating Segments [Member] | Fuel Specialties [Member] | Refinery and Performance [Member]
Segment Reporting Information [Line Items]
Net sales	97.4	89.8	286.5	281.7
Operating Segments [Member] | Fuel Specialties [Member] | Other [Member]
Segment Reporting Information [Line Items]
Net sales	32.7	24.6	91.3	85.4
Operating Segments [Member] | Performance Chemicals [Member]
Segment Reporting Information [Line Items]
Net sales	110.3	36.8	309.7	106.8
Gross profit	20.7	12.3	54.8	34.4
Operating income	9.7	4.2	22.2	13.3
Operating Segments [Member] | Performance Chemicals [Member] | Personal Care [Member]
Segment Reporting Information [Line Items]
Net sales	52.2	33.7	148.4	97.7
Operating Segments [Member] | Performance Chemicals [Member] | Home Care [Member]
Segment Reporting Information [Line Items]
Net sales	32.7	0.5	89	1.4
Operating Segments [Member] | Performance Chemicals [Member] | Other [Member]
Segment Reporting Information [Line Items]
Net sales	25.4	2.6	72.3	7.7
Operating Segments [Member] | Oilfield Services [Member]
Segment Reporting Information [Line Items]
Net sales	81.9	49.7	224.5	132.4
Gross profit	28.5	20.6	82.9	52.1
Operating income	1.8	0	8.5	(7.1)
Operating Segments [Member] | Octane Additives [Member]
Segment Reporting Information [Line Items]
Net sales	10.1	4.6	41	39.3
Gross profit	5	2.5	21.2	24.9
Operating income	4.4	1.9	19.2	22.5
Corporate, Non-Segment [Member]
Segment Reporting Information [Line Items]
Pension credit	1.1	1.6	3.2	5.1
Corporate costs	(11.7)	(15.2)	(34.5)	(37.8)
Segment Reconciling Items [Member]
Segment Reporting Information [Line Items]
Loss on disposal of subsidiary	$ 0	$ 0	$ (1)	$ (1.4)

Segment Reporting - Summary of

Segment Reporting - Summary of Segment Depreciation and Amortization (Detail) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
Summary of segment depreciation and amortization
Depreciation	$ 5.6	$ 3.5	$ 16.1	$ 10.1
Amortization	6.9	6.1	20.6	18.2
Operating Segments [Member] | Fuel Specialties [Member]
Summary of segment depreciation and amortization
Depreciation	1	0.9	3	2.8
Amortization	0.2	0.2	0.6	0.7
Operating Segments [Member] | Performance Chemicals [Member]
Summary of segment depreciation and amortization
Depreciation	2.5	0.5	7	1.6
Amortization	1.9	1.1	5.6	3.1
Operating Segments [Member] | Oilfield Services [Member]
Summary of segment depreciation and amortization
Depreciation	1.6	1.7	4.8	4.6
Amortization	2.9	2.9	8.9	8.9
Operating Segments [Member] | Octane Additives [Member]
Summary of segment depreciation and amortization
Depreciation	0.2	0.1	0.6	0.4
Corporate, Non-Segment [Member]
Summary of segment depreciation and amortization
Depreciation	0.3	0.3	0.7	0.7
Amortization	$ 1.9	$ 1.9	$ 5.5	$ 5.5

Earnings Per Share - Summary of

Earnings Per Share - Summary of Earnings Per Share (Detail) - USD ($) $ / shares in Units, shares in Thousands, $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
Numerator (in millions):
Net income available to common stockholders	$ 23.3	$ 11.4	$ 66.6	$ 59.2
Denominator (in thousands):
Weighted average common shares outstanding	24,137	23,977	24,119	23,989
Dilutive effect of stock options and awards	428	499	450	473
Denominator for diluted earnings per share	24,565	24,476	24,569	24,462
Net income per share, basic:	$ 0.97	$ 0.48	$ 2.76	$ 2.47
Net income per share, diluted:	$ 0.95	$ 0.47	$ 2.71	$ 2.42

Earnings Per Share - Additional

Earnings Per Share - Additional Information (Detail) - shares	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
Earnings Per Share [Abstract]
Average number of anti-dilutive options excluded from the calculation of diluted earnings per share	18,843	0	18,843	0

Goodwill - Summary of Goodwill

Goodwill - Summary of Goodwill (Detail) $ in Millions	9 Months Ended
	Sep. 30, 2017USD ($)
Goodwill and Intangible Assets Disclosure [Abstract]
Gross cost, beginning balance	$ 611.3
Accumulated impairment losses, beginning balance	(236.5)
Net book amount, beginning balance	374.8
Acquisition adjustment	(36.7)
Exchange effect	8.7
Gross cost, ending balance	583.3
Accumulated impairment losses, ending balance	(236.5)
Net book amount, ending balance	$ 346.8

Goodwill - Summary of Goodwil43

Goodwill - Summary of Goodwill (Parenthetical) (Detail) - USD ($) $ in Millions	Sep. 30, 2017	Sep. 30, 2016
Goodwill and Intangible Assets Disclosure [Abstract]
Historical accumulated amortization	$ 298.5	$ 298.5

Goodwill - Additional Informati

Goodwill - Additional Information (Detail) - Huntsman [Member] - USD ($)	Dec. 30, 2016	Sep. 30, 2017	Sep. 30, 2017
Goodwill [Line Items]
Business acquisition, consideration transferred	$ 200,200,000
Decrease in goodwill			$ 36,700,000
Final working capital adjustments		$ 2,600,000
Goodwill amortizable for tax purpose			$ 0

Other Intangible Assets - Summa

Other Intangible Assets - Summary of Other Intangible Assets (Detail) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016	Dec. 31, 2016
Goodwill and Intangible Assets Disclosure [Abstract]
Gross cost at January 1			$ 248.6	$ 248.6
Acquisitions			37.7	0
Internally developed software			4.1	0
Exchange effect			4.1	0
Gross cost at September 30	$ 294.5	$ 248.6	294.5	248.6
Accumulated amortization at January 1			(104.2)	(79.9)
Amortization expense	(6.9)	(6.1)	(20.6)	(18.2)
Exchange effect			(0.1)	0
Accumulated amortization at September 30	(124.9)	(98.1)	(124.9)	(98.1)
Net book amount at September 30	$ 169.6	$ 150.5	$ 169.6	$ 150.5	$ 144.4

Other Intangible Assets - Addit

Other Intangible Assets - Additional Information (Detail) - USD ($) $ in Millions	Aug. 09, 2017	Sep. 30, 2017	Sep. 30, 2016	Mar. 31, 2017
Finite-Lived Intangible Assets [Line Items]
Cash paid for acquisition		$ 4.2	$ 0
Huntsman [Member] | Customer Relationships [Member]
Finite-Lived Intangible Assets [Line Items]
Intangible assets acquired in business combination				$ 33.5
Huntsman Holland B.V. [Member] | Customer and Distributor [Member] | Americas and Asia Pacific [Member]
Finite-Lived Intangible Assets [Line Items]
Cash paid for acquisition	$ 4.2

Other Intangible Assets - Sched

Other Intangible Assets - Schedule of Amortization Expense (Detail) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
Finite-Lived Intangible Assets [Line Items]
Amortization expense	$ (6.9)	$ (6.1)	$ (20.6)	$ (18.2)
Product Rights [Member]
Finite-Lived Intangible Assets [Line Items]
Amortization expense			(2.8)	(2.8)
Brand Names [Member]
Finite-Lived Intangible Assets [Line Items]
Amortization expense			(0.9)	(0.9)
Technology [Member]
Finite-Lived Intangible Assets [Line Items]
Amortization expense			(2.5)	(2.5)
Customer Relationships [Member]
Finite-Lived Intangible Assets [Line Items]
Amortization expense			(7.6)	(5.1)
Non-Compete Agreements [Member]
Finite-Lived Intangible Assets [Line Items]
Amortization expense			(0.6)	(0.7)
Marketing Related [Member]
Finite-Lived Intangible Assets [Line Items]
Amortization expense			(0.7)	(0.7)
Internally Developed Software [Member]
Finite-Lived Intangible Assets [Line Items]
Amortization expense			$ (5.5)	$ (5.5)

Pension Plans - Plan Net Pensio

Pension Plans - Plan Net Pension Credit (Detail) - United Kingdom [Member] - Foreign Pension Plan [Member] - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
Plan net pension credit/(charge):
Service cost	$ (0.2)	$ (0.2)	$ (0.7)	$ (0.7)
Interest cost on projected benefit obligation	(3.9)	(5)	(11.3)	(16)
Expected return on plan assets	6.2	7.2	18.2	23
Amortization of prior service credit	0.2	0.2	0.7	0.8
Amortization of actuarial net losses	(1.2)	(0.6)	(3.7)	(2)
Net pension credit total	$ 1.1	$ 1.6	$ 3.2	$ 5.1

Pension Plans - Additional Info

Pension Plans - Additional Information (Detail) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016	Dec. 31, 2016
Defined Benefit Plan Disclosure [Line Items]
Pension obligations European businesses	$ 16.5		$ 16.5		$ 14.2
Germany [Member] | Foreign Pension Plan [Member]
Defined Benefit Plan Disclosure [Line Items]
Net pension charge	0.1	$ 0.2	0.5	$ 0.6
Europe [Member] | Foreign Pension Plan [Member] | Performance Chemicals [Member]
Defined Benefit Plan Disclosure [Line Items]
Pension obligations European businesses	$ 4.7		$ 4.7		$ 4.1

Income Taxes - Roll-Forward of

Income Taxes - Roll-Forward of Unrecognized Tax Benefits and Associated Accrued Interest and Penalties (Detail) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2017	Dec. 31, 2016
Income Tax Contingency [Line Items]
Opening balance at January 1	$ 2.3
Reductions due to lapsed statute of limitations	(0.5)
Closing balance at September 30	1.8
Current	0
Non-current	1.8	$ 2.3
Unrecognized Tax Benefits [Member]
Income Tax Contingency [Line Items]
Opening balance at January 1	2.2
Reductions due to lapsed statute of limitations	(0.5)
Closing balance at September 30	1.7
Current	0
Non-current	1.7
Interest and Penalties [Member]
Income Tax Contingency [Line Items]
Opening balance at January 1	0.1
Reductions due to lapsed statute of limitations	0
Closing balance at September 30	0.1
Current	0
Non-current	$ 0.1

Income Taxes - Additional Infor

Income Taxes - Additional Information (Detail) - USD ($) $ in Millions	9 Months Ended	12 Months Ended
	Sep. 30, 2017	Dec. 31, 2016
Income Tax Contingency [Line Items]
Income tax examination, description	The Company and its U.S. subsidiaries remain open to examination by the IRS for years 2014 onwards. The Company's subsidiaries in foreign tax jurisdictions are open to examination including France (2014 onwards), Germany (2015 onwards), Switzerland (2015 onwards) and the United Kingdom (2015 onwards).
Unremitted earnings		$ 788
France [Member]
Income Tax Contingency [Line Items]
Open tax year	2,014
Germany [Member]
Income Tax Contingency [Line Items]
Open tax year	2,015
Switzerland [Member]
Income Tax Contingency [Line Items]
Open tax year	2,015
United Kingdom [Member]
Income Tax Contingency [Line Items]
Open tax year	2,015
Italy [Member] | Earliest Tax Year [Member]
Income Tax Contingency [Line Items]
Open tax year	2,011
Italy [Member] | Latest Tax Year [Member]
Income Tax Contingency [Line Items]
Open tax year	2,013

Long-Term Debt - Schedule of Lo

Long-Term Debt - Schedule of Long-Term Debt (Detail) - USD ($) $ in Millions	Sep. 30, 2017	Dec. 31, 2016
Debt Instrument [Line Items]
Deferred finance costs	$ (1.7)	$ (2.2)
Long-term debt	229.3	268.8
Due within one year	(10.3)	(10.3)
Due after one year	219	258.5
Term Loan [Member]
Debt Instrument [Line Items]
Long-term debt	110	110
Revolving Credit Facility [Member]
Debt Instrument [Line Items]
Long-term debt	$ 121	$ 161

Plant Closure Provisions - Move

Plant Closure Provisions - Movements in Plant Closure and Restructuring Provisions (Detail) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Dec. 31, 2016
Restructuring and Related Activities [Abstract]
Beginning Balance	$ 39.5	$ 37.7
Charge for the period	4.4	3.5
Utilized in the period	(1.7)	(2.1)
Exchange effect	0.5	0.1
Ending Balance	42.7	39.2
Due within one year	(5.9)	(5)	$ (6.7)
Due after one year	$ 36.8	$ 34.2	$ 32.8

Fair Value Measurements - Carry

Fair Value Measurements - Carrying Amount and Fair Values of the Company's Assets and Liabilities Measured on a Recurring Basis (Detail) - Recurring [Member] - USD ($) $ in Millions	Sep. 30, 2017	Dec. 31, 2016
Carrying Amount [Member]
Non-derivatives:
Cash and cash equivalents	$ 65.5	$ 101.9
Non-derivatives:
Long-term debt (including current portion)	229.3	268.8
Finance leases (including current portion)	5.8	4.5
Carrying Amount [Member] | Derivatives (Level 1 Measurement) [Member] | Interest Rate Swaps [Member]
Derivatives (Level 1 measurement):
Derivative asset	0.6	0.4
Carrying Amount [Member] | Derivatives (Level 1 Measurement) [Member] | Foreign Currency Forward Exchange Contracts [Member]
Derivatives (Level 1 measurement):
Derivative asset	2	0
Derivatives (Level 1 measurement):
Foreign currency forward exchange contracts	0	0.6
Carrying Amount [Member] | Non-financial Assets and Liabilities (Level 3 Measurement) [Member]
Non-financial liabilities (Level 3 measurement):
Stock equivalent units	11.4	9.8
Fair Value [Member]
Non-derivatives:
Cash and cash equivalents	65.5	101.9
Non-derivatives:
Long-term debt (including current portion)	229.3	268.8
Finance leases (including current portion)	5.8	4.5
Fair Value [Member] | Derivatives (Level 1 Measurement) [Member] | Interest Rate Swaps [Member]
Derivatives (Level 1 measurement):
Derivative asset	0.6	0.4
Fair Value [Member] | Derivatives (Level 1 Measurement) [Member] | Foreign Currency Forward Exchange Contracts [Member]
Derivatives (Level 1 measurement):
Derivative asset	2	0
Derivatives (Level 1 measurement):
Foreign currency forward exchange contracts	0	0.6
Fair Value [Member] | Non-financial Assets and Liabilities (Level 3 Measurement) [Member]
Non-financial liabilities (Level 3 measurement):
Stock equivalent units	$ 11.4	$ 9.8

Derivative Instruments and Ri55

Derivative Instruments and Risk Management - Additional Information (Detail) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016
Maximum [Member]
Derivative [Line Items]
Maturity period of foreign currency forward exchange contracts	12 months
Not Designated as Hedging Instrument [Member] | Foreign Currency Forward Exchange Contracts [Member] | Other net income/(expense) [Member]
Derivative [Line Items]
Amount of gain/(loss) recognized in income	$ (0.6)	$ 3.2
Designated as Hedging Instrument [Member] | Interest Rate Swaps [Member] | Accumulated Other Comprehensive Loss [Member]
Derivative [Line Items]
Amount of gain/(loss) recognized in income	$ 0.2	$ 0

Commitments and Contingencies -

Commitments and Contingencies - Additional Information (Detail) $ in Millions	Sep. 30, 2017USD ($)
Commitments and Contingencies Disclosure [Abstract]
Guarantees	$ 3.3

Stock-Based Compensation Plan57

Stock-Based Compensation Plans - Summary of Transactions of the Company's Stock Option Plans (Detail) - Stock Options Plan [Member]	9 Months Ended
	Sep. 30, 2017$ / sharesshares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Outstanding, Number of Options, Beginning balance | shares	570,994
Exercised, Number of Options | shares	(83,255)
Forfeited, Number of Options | shares	(3,805)
Outstanding, Number of Options, Ending balance | shares	582,441
Outstanding, Weighted Average Exercise Price, Beginning balance	$ 20.38
Exercised, Weighted Average Exercise Price	12.56
Forfeited, Weighted Average Exercise Price	15.91
Outstanding, Weighted Average Exercise Price, Ending balance	20.64
Outstanding, Weighted Average Grant-Date Fair Value	21.68
Exercised	23.86
Forfeited, Weighted Average Grant-Date Fair Value	22.47
Outstanding, Weighted Average Grant-Date Fair Value	$ 26.68
Discount [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Granted, Number of Options | shares	79,664
Granted, Weighted Average Exercise Price	$ 0
Granted, Weighted Average Grant-Date Fair Value	$ 61.39
Market Value [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Granted, Number of Options | shares	18,843
Granted, Weighted Average Exercise Price	$ 70.60
Granted, Weighted Average Grant-Date Fair Value	$ 16.84

Stock-Based Compensation Plan58

Stock-Based Compensation Plans - Additional Information (Detail) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock option compensation	$ 3.4	$ 2.8
Stock Options Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number exercisable and fully vested	44,443
Fully vested stock options with performance conditions attached	9,421
Stock option compensation	$ 3.4	2.8
Total intrinsic value exercised	2	1.8
Total compensation cost related to non-vested stock options not yet recognized	$ 6.7
Expected compensation cost recognized over the weighted-average period	2 years 18 days
Stock Equivalent Units [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Fully vested stock options with performance conditions attached	49,391
Total intrinsic value exercised	$ 1.1	1.5
Expected compensation cost recognized over the weighted-average period	1 year 11 months 4 days
Number of exercisable SEUs	54,759
Compensation cost	$ 3.6	$ 3.7

Stock-Based Compensation Plan59

Stock-Based Compensation Plans - Summarizes Transactions of SEUs (Detail) - Stock Equivalent Units [Member]	9 Months Ended
	Sep. 30, 2017$ / sharesshares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Outstanding, Weighted Average Exercise Price, Beginning balance	$ 3.77
Granted at discount, Weighted Average Exercise Price	0
Granted at market value, Weighted Average Exercise Price	70.60
Exercised, Weighted Average Exercise Price	5.47
Forfeited, Weighted Average Exercise Price	0
Outstanding, Weighted Average Exercise Price, Ending balance	$ 3.03
Outstanding, Number of SEUs, Beginning balance | shares	279,815
Granted at discount, Number of SEUs | shares	180,249
Granted at market value, Number of SEUs | shares	5,530
Exercised, Number of SEUs | shares	(34,054)
Forfeited, Number of SEUs | shares	(16,075)
Outstanding, Number of SEUs, Ending balance | shares	415,465
Outstanding, Weighted Average Grant-Date Fair Value	$ 33.40
Granted at discount, Weighted Average Grant-Date Fair Value	62.76
Granted at market value, Weighted Average Grant-Date Fair Value	16.84
Exercised, Weighted Average Grant-Date Fair Value	27.09
Forfeited, Weighted Average Grant-Date Fair Value	33.77
Outstanding, Weighted Average Grant-Date Fair Value	$ 46.41

Reclassifications out of Accu60

Reclassifications out of Accumulated Other Comprehensive Loss - Summary of Reclassifications out of Accumulated Other Comprehensive Loss (Detail) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Liquidation of subsidiary	$ 0	$ 0	$ 1.8	$ 0
Total reclassifications			(2.5)
Foreign Currency Translation Items [Member]
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Total reclassifications			0
Defined Benefit Pension Plan Items [Member]
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Total reclassifications			(2.5)
Reclassification Out of Accumulated Other Comprehensive Income/(Loss) [Member]
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Total before tax			4.8
Income tax expense			(0.5)
Total reclassifications			4.3
Reclassification Out of Accumulated Other Comprehensive Income/(Loss) [Member] | Foreign Currency Translation Items [Member]
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Liquidation of subsidiary			1.8
Reclassification Out of Accumulated Other Comprehensive Income/(Loss) [Member] | Defined Benefit Pension Plan Items [Member]
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Amortization of prior service credit			(0.7)
Amortization of actuarial net losses			$ 3.7

Reclassifications out of Accu61

Reclassifications out of Accumulated Other Comprehensive Loss - Changes in Accumulated Other Comprehensive Loss (Detail) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
Accumulated Other Comprehensive Income (Loss) [Line Items]
Beginning Balance			$ 653.5
Other comprehensive income before reclassifications			30.9
Amounts reclassified from AOCL			2.5
Total other comprehensive income	$ 19.2	$ 0.2	33.4	$ 0.6
Ending Balance	747.5		747.5
Accumulated Other Comprehensive Loss [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Beginning Balance			(126.2)
Ending Balance	(92.8)		(92.8)
Derivative Instruments [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Beginning Balance			0.3
Other comprehensive income before reclassifications			0.2
Amounts reclassified from AOCL			0
Total other comprehensive income			0.2
Ending Balance	0.5		0.5
Defined Benefit Pension Plan Items [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Beginning Balance			(46)
Other comprehensive income before reclassifications			0
Amounts reclassified from AOCL			2.5
Total other comprehensive income			2.5
Ending Balance	(43.5)		(43.5)
Foreign Currency Translation Items [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Beginning Balance			(80.5)
Other comprehensive income before reclassifications			30.7
Amounts reclassified from AOCL			0
Total other comprehensive income			30.7
Ending Balance	$ (49.8)		$ (49.8)

Related Party Transactions - Ad

Related Party Transactions - Additional Information (Detail) - Smith, Gambrell & Russell, LLP [Member] - USD ($) $ in Millions	Sep. 30, 2017	Dec. 31, 2016	Sep. 30, 2016
Related Party Transaction [Line Items]
Fees payable to Smith, Gambrell & Russell	$ 0.3		$ 0.4
Amount due to Smith, Gambrell & Russell	$ 0	$ 0